September 21-24, 2000

The meeting is organised as a two-part, coordinated symposium. Part I is the Annual Meeting of the EASD Islet Study Group, Part II is a workshop on Alternative Cell Sources for Islet Transplantation. The programme consists of invited lectures and free communications, and has been established by two interacting scientific committees.

PART I: ANNUAL MEETING OF EASD ISLET STUDY GROUP

I - Control of exocytosis in ß-cells
Chairpersons: C. Wollheim, Geneva; B. Glaser, Jerusalem
Speakers: S. Seino, Chiba; R. Nesher, Jerusalem; P. Halban, Geneva; G.W. Sharp, Ithaca

II - Autocrine and endocrine regulation of ß-cell function
Chairpersons: S. Efendic, Stockholm; D.J. Gross, Jerusalem
Speakers: H. Okamoto, Sendai; B. Leibiger, Stockholm; J.J. Holst, Copenhagen

III - Regulation of islet-specific genes
Chairpersons: J. Jami, Paris; G. Leibowitz, Jerusalem
Speakers: D. Melloul, Jerusalem; M. Walker, Rehovot; J. Philippe, Geneva

IV - ß-Cell turnover in diabetes
Chairpersons: C. Hellerstrom, Uppsala; D. Eizirik, Brussels
Speakers: A. Ktorza, Paris; N. Kaiser, Jerusalem; Y. Kajimoto, Osaka; C. Boitard, Paris

V - Developmental biology of the islet
Chairpersons: D.F. Steiner, Chicago; M. Walker, Rehovot
Speakers: O. Madsen, Gentofte; G. Gittes, New York; L. Bouwens, Brussels

PART II: ALTERNATIVE CELL SOURCES FOR ISLET TRANSPLANTATION
VI - Engineering ß- and non-ß-cells for transplantation (combined session)
Chairpersons: C. Newgard, Dallas; J. Itskovitz-Eldor, Haifa
Speakers: M. Stoffel, New York; S. Bonner-Weir, Boston; S. Efrat, Tel Aviv; C. Newgard, Dallas; S. Ferber, Tel Aviv; I. Wilmut, Roslin

VII - Human and pig islets
Chairpersons: R. Rajotte, Edmonton; A. Yusim, Tel Aviv
Speakers: B. Hering, Minneapolis; R. Rajotte, Edmonton; C.G. Groth, Stockholm

VIII - Alternative sources for human transplantation
Chairpersons: B. Hering, Minneapolis; P. Vardi, Haifa
Speakers: L. Harrison, Melbourne; B. Soria, Alicante; F. Bach, Boston

IX - Protection and induction of tolerance
Chairpersons: R. Gil, Denver; R. Nakash, Tel Aviv
Speakers: R. Gil, Denver; T. Strom, Boston; S. Slavin, Jerusalem; G. Weir, Boston

Eilat, Israel

Part I - E. Cerasi, Jerusalem, Israel
Part II - P. Vardi, Haifa, Israel and G.C. Weir, Boston, USA

Servier 
Novartis
EASD
Lilly Forschung
Eli Lilly
Joslin Clinic
Modex Therapeutics
Novo Nordisk
Biomedical Investments
Frezenius
Carmel Biosensors
Roche Israel
Israel Diabetes Association

FOR REGISTRATION AND ACCOMMODATION ENQUIRIES
www.congress.co.il/islets

FOR ABSTRACT ENQUIRIES
Erol Cerasi (erol@md2.huji.ac.il),
Pnina Vardi (pvardi@post.tau.ac.il)
Gordon Weir (Gordon.Weir@joslin.harvard.edu).